4//SEC Filing
QUAKER BIO VENTURES LP 4
Accession 0001104659-11-018945
CIK 0001274644other
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 5:14 PM ET
Size
12.3 KB
Accession
0001104659-11-018945
Insider Transaction Report
Form 4
TRANZYME INCTZYM
QUAKER BIO VENTURES LP
10% Owner
Transactions
- Conversion
Common Stock
2011-04-06+2,189,791→ 2,189,791 total - Conversion
Series A Convertible Preferred Stock
2011-04-06−15,328,551→ 0 total→ Common Stock (2,189,791 underlying) - Purchase
Common Stock
2011-04-06$4.00/sh+375,000$1,500,000→ 2,564,791 total
QUAKER BIOVENTURES CAPITAL LP
10% Owner
Transactions
- Conversion
Series A Convertible Preferred Stock
2011-04-06−15,328,551→ 0 total→ Common Stock (2,189,791 underlying) - Conversion
Common Stock
2011-04-06+2,189,791→ 2,189,791 total - Purchase
Common Stock
2011-04-06$4.00/sh+375,000$1,500,000→ 2,564,791 total
Gavin Brenda D
Director
Transactions
- Conversion
Common Stock
2011-04-06+2,189,791→ 2,189,791 total - Purchase
Common Stock
2011-04-06$4.00/sh+375,000$1,500,000→ 2,564,791 total - Conversion
Series A Convertible Preferred Stock
2011-04-06−15,328,551→ 0 total→ Common Stock (2,189,791 underlying)
Footnotes (3)
- [F1]Each share of the Issuer's Series A Convertible Preferred Stock automatically converted, for no additional consideration, into shares of Common Stock prior to the closing of the Issuer's initial public offering on a 7-for-1 basis, reflecting a 1-for-7 reverse stock split which became effective on March 31, 2011.
- [F2]These securities are owned of recored by Quaker BioVentures, L.P. ("Quaker"). Quaker BioVentures Capital, L.P. is the managing partner of Quaker and has voting and dispositive power over the shares held by Quaker. Voting and investment decisions made by Quaker BioVentures Capital, L.P. with respect to the shares held by Quaker are made by an investment committee comprised of the following managers of Quaker BioVentures Capital, L.P.: Brenda D. Gavin, P. Sherrill Neff and Ira M. Lubert, each of whom disclaims beneficial ownership of such securities except to the extent of his or her pecuniary interest therein.
- [F3]These shares were purchased in the Issuer's initial public offering.
Documents
Issuer
TRANZYME INC
CIK 0001274644
Entity typeother
Related Parties
1- filerCIK 0001170144
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 5:14 PM ET
- Size
- 12.3 KB